Moreover, metastasis is virtually prevented in mice when treated with a murine-specific version of adecatumumab[74], which suggests that this combination has the potential to be a long-term treatment strategy for the management of ER+ breast cancer as a chronic condition in elderly patients[75]. This evidence concerns the gene ESR1 and breast carcinoma.